8-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D)

OF THE SECURITIES EXCHANGE ACT OF 1934

January 4, 2021

Date of report (Date of earliest event reported)

IMAX Corporation

(Exact Name of Registrant as Specified in Its Charter)

(Address of principal executive offices, zip code, telephone numbers)

N/A

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Securities registered pursuant to Section 12(b) of the Act:

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter):

Emerging growth company  ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

Compensation Arrangements with other Named Executive Officers

On January 4, 2021, the Compensation Committee of the Board of Directors (the “Committee”) of IMAX Corporation (the “Company”) approved a one-time grant of time-vesting restricted stock units (“RSUs”) with a grant value of $400,000 under the Company’s Second Amended and Restated Long-Term Incentive Plan to its Chief Executive Officer, Richard Gelfond (the “Executive Retention Award”). The Executive Retention Award was granted in lieu of a cash bonus for Mr. Gelfond for 2020, who has an annual target bonus of $1.2 million. The RSUs will vest over two years and be subject to forfeiture to the extent of an event of voluntary termination prior to end of the vesting period.

Under Mr. Gelfond’s leadership during the COVID-19 crisis, swift and decisive actions were taken to protect the Company amid the uncertainty of the pandemic including drawing down its revolving credit facility in March, amending its existing credit agreement to provide maximum financial and operating flexibility, executing on significant cost reductions, including non-essential SG&A and capital expenditures, overseeing the seamless reopening and ramp up of the Company’s Asian theater network, which is close to 100% operational, and returning the Company’s stock price to pre-pandemic levels.

2

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

3